Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Craddock

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
Blood|November 8, 2003
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsFiona J Clark, Richard Gregg, Karen Piper, et al.
Blood|June 10, 2010
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasiaOliver Goodyear, Angelo Agathanggelou, Igor Novitzky-Basso, et al.
Haematologica|August 1, 2009
Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromesNicolas Goardon, Emmanouil Nikolousis, Alexander Sternberg, et al.
Haematologica|October 14, 2021
Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trialNigel H Russell, Robert K Hills, Abin Thomas, et al.
British Journal of Haematology|January 16, 2014
Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responsesBenjamin Uttenthal, Irma Martinez-Davila, Adam Ivey, et al.
Blood Advances|January 4, 2018
The number of CD56<sup>dim</sup> NK cells in the graft has a major impact on risk of disease relapse following allo-HSCTLuke Maggs, Francesca Kinsella, Y L Tracey Chan, et al.
BMC Cancer|October 2, 2012
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samplesVictoria J Spanswick, Helen L Lowe, Claire Newton, et al.
Haematologica|May 13, 2010
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effectAndrew McLarnon, Karen P Piper, Oliver C Goodyear, et al.
International Journal of Cancer|November 29, 2018
Targeting the arginine metabolic brake enhances immunotherapy for leukaemiaFrancis Mussai, Rachel Wheat, Evgenia Sarrou, et al.
Transplantation|January 28, 2003
Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host diseaseFiona J Clark, Lisa Freeman, Andrzej Dzionek, et al.
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Blood|November 8, 2003
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsFiona J Clark, Richard Gregg, Karen Piper, et al.
Blood|June 10, 2010
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasiaOliver Goodyear, Angelo Agathanggelou, Igor Novitzky-Basso, et al.
Haematologica|August 1, 2009
Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromesNicolas Goardon, Emmanouil Nikolousis, Alexander Sternberg, et al.
Haematologica|October 14, 2021
Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trialNigel H Russell, Robert K Hills, Abin Thomas, et al.
British Journal of Haematology|January 16, 2014
Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responsesBenjamin Uttenthal, Irma Martinez-Davila, Adam Ivey, et al.
Blood Advances|January 4, 2018
The number of CD56<sup>dim</sup> NK cells in the graft has a major impact on risk of disease relapse following allo-HSCTLuke Maggs, Francesca Kinsella, Y L Tracey Chan, et al.
BMC Cancer|October 2, 2012
Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samplesVictoria J Spanswick, Helen L Lowe, Claire Newton, et al.
Haematologica|May 13, 2010
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effectAndrew McLarnon, Karen P Piper, Oliver C Goodyear, et al.
International Journal of Cancer|November 29, 2018
Targeting the arginine metabolic brake enhances immunotherapy for leukaemiaFrancis Mussai, Rachel Wheat, Evgenia Sarrou, et al.
Transplantation|January 28, 2003
Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host diseaseFiona J Clark, Lisa Freeman, Andrzej Dzionek, et al.
Pageof 17